OBP Ondine Biomed

 
TIDMOBP 
 
Circ re: Ondine Biopharma Corporation ("Ondine Biopharma" or the "Company") Publication of Information Circular and Mail Out of Financial Statements, MD&A and Shareholder Meeting Materials 
FOR:  ONDINE BIOPHARMA CORPORATION 
 
TSX, AIM SYMBOL:  OBP 
 
May 20, 2010 
 
Ondine Biopharma Corporation ("Ondine Biopharma" or the "Company") Publication of Information Circular and Mail 
Out of Financial Statements, MD&A and Shareholder Meeting Materials 
 
VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 20, 2010) - Ondine Biopharma (TSX:OBP)(AIM:OBP) announces that, 
in accordance with regulatory requirements, it has mailed out its Financial Statements and Management 
Discussion and Analysis (MD&A) for the year ended December 31, 2009 as well as its Information Circular, Notice 
of Meeting and related proxy materials on May 19, 2010, in connection with the Company's annual general and 
special meeting to be held on Thursday, June 17, 2010 at 10:00 A.M. (the "Meeting") at the Company's office at 
910-1100 Melville Street, Vancouver, British Columbia, Canada. Copies of these documents are available during 
normal business hours on weekdays (except Saturdays, Sundays and public holidays) free of charge from the 
Company's office at 910-1100 Melville Street, Vancouver, British Columbia, Canada. In addition, these documents 
are available on the SEDAR website at www.sedar.com and on the Company's website at www.ondinebiopharma.com. 
 
 
-30- 
 
FOR FURTHER INFORMATION PLEASE CONTACT: 
 
Ondine Biopharma Corporation 
Carolyn Cross 
Chairman and Chief Executive Officer 
(604) 669-0555 
ccross@ondinebiopharma.com 
www.ondinebiopharma.com 
 
OR 
 
Canaccord Genuity Limited 
Ryan Gaffney 
Nominated Adviser 
+4420 7050 6500 
 
 
 
 
 
Ondine Biopharma Corporation 
 

Ondine Biomed (LSE:OBP)
Historical Stock Chart
From May 2024 to Jun 2024

Ondine Biomed (LSE:OBP)
Historical Stock Chart
From Jun 2023 to Jun 2024